Side Effects of TRT: Testosterone Replacement Therapy Risks, Timeline, and What to Expect

Most of the men and women who come to me about testosterone arrive with a legitimate clinical problem: persistent fatigue, low libido, cognitive fog, and unequivocally low serum testosterone on repeat morning labs consistent with testosterone deficiency.

Along with that, they usually ask a fair question: what can go wrong? That deserves a clear-eyed answer, not reassurance.

In my practice, I tell patients the adverse effects of testosterone replacement therapy fall into two categories, and the two behave very differently. There are the common, expected, largely manageable effects, and there are the rare, serious ones that warrant a phone call or a dose change.

Just as importantly, side effects arrive on a schedule. Some show up in the first weeks; others only after a year.

This guide organizes the risks of testosterone therapy the way I actually counsel patients: by how common they are, when they appear, and whether they reverse.

What Are the Side Effects of TRT? A Common-vs-Rare Framework

The single most useful mental model for the side effects of TRT is a two-tier one. The first tier is common and expected: acne, mild fluid retention, a rising hematocrit. I monitor and manage these rather than treat them as reasons to abandon therapy.

The second tier is rare and serious: a thrombotic event, a hematocrit climbing toward a dangerous ceiling. These are the ones that prompt me to hold or adjust a dose.

The table below is the framework I return to throughout this article, because no honest discussion of testosterone therapy treats every risk as equal.

Side Effect	How Common	Typical Onset	Reversible on Discontinuation?
Acne / oily skin	Common	Weeks 1-6	Yes, resolves within weeks
Fluid retention / ankle swelling	Common	Weeks 1-6	Yes, resolves within weeks
Erythrocytosis (elevated hematocrit)	Common	Months 3-6	Yes, normalizes over weeks to months
Gynecomastia	Uncommon	Months 3-6+	Partially, established glandular tissue may persist
Worsening obstructive sleep apnea	Uncommon	Months 3-6	Yes, typically
Testicular shrinkage / fertility suppression	Common	Months 3-12	Usually, but may be incomplete without hCG support
Elevated blood pressure	Common	Months 3-6	Yes, typically
Venous thromboembolism	Rare / serious	Any point	Event-dependent; requires urgent care

The blood-pressure row deserves emphasis: on the strength of postmarket monitoring studies, the FDA added a class-wide warning in February 2025 that testosterone products can raise blood pressure, a change made in the same order that removed the older cardiovascular boxed warning.

Physiologic Replacement vs. Supraphysiologic Dosing

Much of what circulates in the popular imagination about the side effects of testosterone comes from supraphysiologic exposure (the bodybuilding-style dosing that pushes testosterone levels far above the physiologic range), not from standard clinical protocols.

The Endocrine Society guideline is explicit on this point: when clinicians initiate testosterone therapy, they should aim for concentrations in the mid-normal range, not the ceiling.

That distinction changes the entire risk conversation. A man restored to a physiologic testosterone level with careful monitoring is a fundamentally different case from someone chasing a supraphysiologic number, and I counsel the two very differently.

Physical Side Effects of TRT and Testosterone Injections

The physical effects of TRT are best understood chronologically, because the timing of a symptom is a strong clue to its cause and its management.

The most frequently reported physical side effects of testosterone include acne and oily skin, fluid retention, erythrocytosis, gynecomastia, worsening sleep apnea, testicular shrinkage, and shifts in lipids and blood pressure.

Below, I walk through them by the window in which they typically appear.

Weeks 1-6: Early Physical Changes

• Injection-site reactions: soreness or a transient nodule after an intramuscular testosterone injection.

• Early fluid retention, sometimes noticed as mild ankle swelling or a few pounds of water weight.

• Acne flare and oilier skin, driven by increased sebaceous activity.

• Mild mood lift that can shade into irritability, an overlap I address in the mental-health section below.

These early effects of testosterone replacement are the most common and, reassuringly, the most reversible. They rarely justify stopping therapy.

Months 3-6: Erythrocytosis, Hematocrit, and Lipid Shifts

The most clinically important physical side effect in this window is erythrocytosis, a testosterone-driven rise in red-cell mass and hematocrit.

Testosterone stimulates erythropoiesis, and in a meta-analysis of randomized placebo-controlled trials, testosterone treatment carried an odds ratio of 3.69 (95% CI 1.82-7.51) for a hematocrit above 50 percent compared with placebo. Left unwatched, an elevated hematocrit increases blood viscosity and thrombotic risk, which is exactly why monitoring is non-negotiable.

Here is the cadence I use and the threshold that governs it. Per the Endocrine Society, clinicians should check hematocrit at baseline, at 3 to 6 months, and annually thereafter, and should withhold testosterone if hematocrit exceeds 54 percent, allow it to normalize, then resume at a lower dose.

Lipid shifts can also appear in this period. They’re monitored on the same panel and are generally modest at physiologic dosing.

Year 1+: Prostate, Cardiovascular, and Fertility Considerations

Testosterone therapy suppresses the hypothalamic-pituitary-gonadal axis, which lowers intratesticular testosterone and impairs spermatogenesis, the mechanism behind both testicular shrinkage and reduced fertility.

For men who wish to preserve fertility, this isn’t a reason to forgo treatment; it’s a reason to co-manage. In appropriate patients, I use human chorionic gonadotropin (hCG) or a selective estrogen receptor modulator (SERM) alongside or instead of standard TRT to maintain intratesticular signaling.

The Endocrine Society states that testosterone therapy is not recommended for men planning fertility in the near term, so this conversation belongs at the outset, not after a year on therapy.

On cardiovascular risk, the evidence has genuinely shifted. The landmark TRAVERSE trial randomized 5,246 men aged 45 to 80 with hypogonadism and preexisting or high cardiovascular risk, and found testosterone noninferior to placebo for major adverse cardiac events. That result corrects the oversimplified “TRT causes heart attacks” narrative, but it’s not a blanket clearance.

The same trial signaled more atrial fibrillation and venous thromboembolism in the testosterone arm, and testosterone may still warrant caution in men with prior thromboembolic events.

For readers who want the full picture, I unpack the trial data and its caveats in my expert review of testosterone replacement therapy in men with cardiovascular risk. 

On the prostate: current data do not establish a causal link between testosterone therapy and prostate cancer. The Endocrine Society nonetheless recommends assessing prostate cancer risk before starting and again 3 to 12 months after initiating therapy in men who elect monitoring, with PSA as part of that surveillance.

How Delivery Method Changes the Side-Effect Profile

The form of testosterone matters as much as the dose, because each delivery method produces a different peak-and-trough curve, and those pharmacokinetics drive symptom fluctuation.

A long-acting ester such as testosterone undecanoate injected every one to two weeks behaves nothing like a daily topical gel. The table below summarizes what I look for with each.

Delivery Method	Peak-and-Trough Pattern	Characteristic Side Effects
IM injection (cypionate / enanthate)	Pronounced peak after injection, trough before the next dose	Greater tendency toward erythrocytosis; cycle-linked mood swings tracking the peak-to-trough swing
Subcutaneous micro-dosing	Steadier levels with smaller peaks and troughs	Smoother mood and energy; often less erythrocytosis than large IM boluses
Topical gel	Daily application, relatively stable once absorbed	Skin-transfer risk to partners and children; absorption variability
Pellet	Sustained release over months, no daily fluctuation	Insertion-site issues (extrusion, infection); dose cannot be dialed back once implanted
Patch	Daily, transdermal, fairly steady	Skin irritation at the application site

The clinical lesson is that a patient with cycle-linked mood swings on a large weekly injection often does markedly better on smaller, more frequent subcutaneous dosing (a protocol change, not a new drug).

This is exactly the kind of physical risk that gets managed rather than gambled on. At Elite Medical Associates, the structured lab protocols we use (baseline, interval, and annual panels reviewed by a physician) are how these risks are caught early and corrected, not left to chance.

Mental and Mood-Related Side Effects of Testosterone Injections

The mental side effects of testosterone injections are underserved in most patient-facing material, which is unfortunate, because they’re among the most common reasons patients call.

Mood swings, irritability, anxiety, low mood, and occasionally aggression all appear in clinical practice, but the direction of the effect depends entirely on context.

In a genuinely hypogonadal patient, restoring a normal testosterone level frequently improves mood and lifts the depressive symptoms that low testosterone can produce. This is one of the underappreciated benefits of testosterone when deficiency is the true root cause.

Supraphysiologic dosing or a wide peak-to-trough swing, by contrast, can destabilize mood, producing a “high” after an injection and a crash before the next one.

Because the swing itself is often the culprit, the fix is usually pharmacokinetic. Moving a patient from a single weekly testosterone injection to twice-weekly or subcutaneous dosing flattens the curve and, in my experience, smooths out much of the mood variability without changing the total weekly dose.

Red Flags: When Mood Changes Warrant a Call to Your Physician

I give every patient a short, explicit list of escalation criteria. Contact your physician promptly, or seek emergency care, if you experience:

• Sudden, uncharacteristic aggression or rage.

• Any thoughts of self-harm or suicidal ideation.

• Severe or escalating anxiety or panic.

• A depressive episode that worsens rather than improves after starting therapy.

These aren’t effects to “wait out.” They’re signals that the protocol needs review.

Side Effects of TRT in Women: Low-Dose Androgen Therapy Risks

Women are prescribed low-dose testosterone in specific clinical contexts, and they deserve a side-effect discussion built for their physiology rather than borrowed from men’s.

The androgenic effects to watch for are acne, hair changes (both scalp thinning and increased facial or body hair), deepening of the voice, and clitoromegaly. At standard physiologic transdermal doses (e.g., 5–10 mg/day), voice change and significant clitoromegaly are rare, but vigilance is still warranted.

The critical distinction, and the one most sources omit, is between dose-dependent and permanent effects. Acne and hair changes are typically dose-dependent and reversible when the dose is lowered or stopped. Voice deepening and clitoromegaly, by contrast, can become irreversible with prolonged supraphysiologic androgen exposure.

Reference ranges and dosing frameworks for female androgen use are well documented by academic centers such as UCSF, and the guiding principle is the same one I apply everywhere: keep exposure physiologic and monitor deliberately.

Which Side Effects of TRT Are Reversible vs. Permanent?

“Will this go away if I stop?” is one of the most common questions I hear, and the honest answer is: it depends on which side effect and how long the exposure lasted. Grouping them helps:

• Reverses within weeks of stopping: fluid retention, acne, oily skin.

• Reverses over weeks to months: erythrocytosis, elevated hematocrit, lipid and blood-pressure shifts.

• May be permanent regardless of timing: voice deepening and clitoromegaly in women after prolonged supraphysiologic exposure; testicular atrophy in some long-term male users who were never supported with hCG.

What Happens When You Stop TRT? Post-Therapy Withdrawal

Stopping testosterone isn’t a light switch. Because exogenous testosterone suppresses the HPG axis, the body’s own production doesn’t resume instantly when therapy ends.

During recovery, many patients experience a temporary return of hypogonadal symptoms (fatigue, low libido, low mood) that can feel worse than their pre-treatment baseline until endogenous production recovers.

This is why I don’t endorse abrupt discontinuation. When a patient wants to come off, we plan a taper or a structured restart protocol, sometimes with a SERM, to shorten that trough rather than let it run unmanaged.

The TRT Monitoring Schedule: Labs, Intervals, and What They Catch

Side-effect management is fundamentally a monitoring problem, not a guessing problem. The schedule I use mirrors the Endocrine Society’s standardized plan: evaluate symptoms, adverse effects, serum testosterone, and hematocrit during the first year, with follow-up structured accordingly.

• Baseline: total testosterone, hematocrit, PSA (where indicated), lipids, and estradiol.

• 3-month follow-up: testosterone level to confirm we’re in the mid-normal range, plus hematocrit.

• 6-month follow-up: repeat hematocrit, PSA, lipids, and estradiol; reassess symptoms.

• Annually thereafter: the full panel, with any interim checks a symptom demands.

One pre-treatment step is frequently skipped: screening for obstructive sleep apnea. The Endocrine Society lists untreated severe obstructive sleep apnea as a condition against starting testosterone, which makes it a genuine safety gate before initiation, not an afterthought.

Sleep and testosterone are tightly coupled: one week of five-hour nights lowers daytime testosterone by 10 to 15 percent in healthy young men, which is why I address sleep before and during therapy, a relationship I explore in our article on testosterone and sleep.

Estradiol Management: Why Aromatase Inhibitors Are Often Overused

A portion of testosterone is converted to estradiol by the enzyme aromatase, and some estrogen is not merely tolerable but necessary for bone, libido, and mood.

In my observation, aromatase inhibitors are prescribed far too reflexively, on the basis of a lab number alone rather than symptoms.

I treat estradiol when a patient has symptomatic elevation, not because a value crossed an arbitrary line on a report. Crushing estradiol to chase a “perfect” ratio typically produces more harm than the mild elevation it was meant to fix.

Talk to a Physician Before Starting or Adjusting TRT

If there’s one idea I want a reader to carry away, it’s this: the side effects of TRT are, overwhelmingly, a monitoring problem rather than a guessing problem.

Nearly every risk in this article is either caught early on a scheduled lab panel or prevented by the right dose in the right form for the right patient. That’s the entire premise of physician-supervised care.

At Elite Medical Associates in Las Vegas, our approach to testosterone replacement therapy is built on structured lab monitoring and dose titration by a board-certified physician, the same framework I’ve described here, applied to your individual biology.

If you’re considering starting testosterone, or you’re already on therapy and want it managed with genuine clinical rigor, schedule a physician-supervised evaluation before you take your next dose.